Literature DB >> 6849951

Slower removal of intestinal apolipoprotein B-48 than of apolipoprotein B-100 in severely hypertriglyceridemic subjects.

P J Nestel, T Billington, N H Fidge.   

Abstract

Apolipoprotein B, the major structural protein of triacylglycerol-rich lipoprotein, occurs in two immunologically distinct forms, termed apolipoproteins B-100 and B-48. In man, the former is associated with triacylglycerol-rich lipoproteins of hepatic origin and the latter with intestinal triacylglycerol-rich lipoproteins. We have studied the rates of removal of the two proteins when 125I-labelled triacylglycerol-rich lipoproteins were reinjected into six severely hypertriglyceridemic subjects showing hyperchylomicronemia, and into two normal subjects. The specific radioactivities of apolipoproteins B-100 and B-48 were determined over periods of up to 30 h. In all six hyperlipemic subjects the removal of apolipoprotein B-100 was either significantly faster than that of apolipoprotein B-48 (in four) or similar in the two who cleared triacylglycerol-rich lipoproteins very slowly. When triacylglycerol-rich lipoproteins from two hyperlipemic subjects (in whom apolipoprotein B-48 was cleared more slowly) were injected into two normal subjects both B apolipoproteins were cleared at similar rates. Since apolipoprotein B-48 appears to be a marker for remnants of intestinal particles, its slower removal than that of apolipoprotein B-100 in severe hypertriglyceridemia suggests that one metabolic defect associated with the hyperchylomicronemia is defective removal of chylomicron remnants.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849951     DOI: 10.1016/0005-2760(83)90301-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Intestinally derived lipoprotein particles in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia.

Authors:  A Curtin; P Deegan; D Owens; P Collins; A Johnson; G H Tomkin
Journal:  Acta Diabetol       Date:  1995-12       Impact factor: 4.280

2.  Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans.

Authors:  A F Stalenhoef; M J Malloy; J P Kane; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

3.  Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans.

Authors:  B O Schneeman; L Kotite; K M Todd; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

4.  Familial apolipoprotein E deficiency.

Authors:  E J Schaefer; R E Gregg; G Ghiselli; T M Forte; J M Ordovas; L A Zech; H B Brewer
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

5.  Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.

Authors:  C J Packard; A Munro; A R Lorimer; A M Gotto; J Shepherd
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.